Massachusetts Institute of Technology’s Burning Rock Biotech BNR Stock Holding History

Massachusetts Institute of Technology’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$349K	Buy	+1,510	New	+$405K	0.39%	9

Other funds holding BNR

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Massachusetts Institute of Technology's BNR Position: Q4 2020 in Review

Massachusetts Institute of Technology opened a new position in Burning Rock Biotech (BNR) in Q4 2020: 1,510 shares worth $349K. The stake represents 0.39% of the portfolio and ranks #9 among its holdings.

58 funds tracked by Wall St. Rank hold BNR as of Q4 2020.

Massachusetts Institute of Technology held 1,510 shares of Burning Rock Biotech worth $349K as of Q4 2020.
Burning Rock Biotech was a new Massachusetts Institute of Technology position in Q4 2020.
Burning Rock Biotech made up 0.39% of Massachusetts Institute of Technology's portfolio in Q4 2020, its #9 holding.
58 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q4 2020.

Based on Massachusetts Institute of Technology's 13F filing for Q4 2020, filed 5 Feb 2021.